HerAnova Lifesciences

Call Directions Website Contact the practice

HerAnova Lifesciences We are advancing innovative women’s health solutions with a focus on endometriosis and infertility.

HerAnova has won Femtech Company of the Year at the Health Tech World Awards 2026!The award recognizes an outstanding co...
11/04/2026

HerAnova has won Femtech Company of the Year at the Health Tech World Awards 2026!

The award recognizes an outstanding company using technology to advance women's health, honoring its exceptional commitment to unmet healthcare needs and meaningful impact on women's lives.

We developed HerResolve™, our blood-based test designed to aid in endometriosis diagnosis in symptomatic women, with a clear purpose: helping women move from unexplained symptoms toward a clear answer to make informed decisions about their health.

We're proud to celebrate this award and grateful to our team, clinicians, and collaborators who help bring our work into practice.

Thank you to Health Tech World and category sponsor Cross-Border Impact Ventures for this honor!

Read the full announcement on our website: https://heranova.com/2026/11/04/11-04-2026/

Explore the winners across all Health Tech World Awards categories: https://htworld.co.uk/health-tech-world-awards/health-tech-world-awards-2026-winners-revealed-af26/

Endometriosis can go unrecognized until patients seek fertility care.In case you missed it: Mohammad Ali, PhD, shares in...
11/02/2026

Endometriosis can go unrecognized until patients seek fertility care.

In case you missed it: Mohammad Ali, PhD, shares insights from Farideh Bischoff, PhD, HerAnova's Chief Medical Officer – Head of Diagnostics, in an Xtalks Webinars article on advancing non-invasive endometriosis testing.

Dr. Bischoff discusses how identifying the condition could give patients and clinicians more time to talk through care and pregnancy planning. She also explains why researchers are studying multiple biological signals together and why emerging tests need validation across different patient populations.

Her perspective is also featured in the September issue of Xtalks Clinical Edge™, written by Soumya Shashikumar, MBiotech.

Thank you, Dr. Ali and Soumya, for sharing these insights with the Xtalks community!

Read the article: https://xtalks.com/endometriosis-testing-closing-the-diagnostic-gap-with-multiomics-and-ai-4956/

Explore the September newsletter: https://xtalks.com/xtalks-clinical-edge-issue-11/

Women's health isn't a one-solution challenge.HerAnova's pipeline is designed to address that complexity. Alongside HerR...
10/27/2026

Women's health isn't a one-solution challenge.

HerAnova's pipeline is designed to address that complexity. Alongside HerResolve™, our commercially available blood-based diagnostic test for endometriosis, our pipeline includes programs in clinical development spanning microbiome-based screening, uterine and vaginal microbiome testing, and ovarian reserve assessment.

Together, these programs reflect an integrated approach focused on non-invasive and minimally invasive solutions for endometriosis and female fertility.

Explore our pipeline: https://heranova.com/pipeline/

📍 We've landed in Baltimore for  !And so have our newly redesigned HerResolve™ shipper kits! 📦The HerAnova team is excit...
10/25/2026

📍 We've landed in Baltimore for !

And so have our newly redesigned HerResolve™ shipper kits! 📦

The HerAnova team is excited to be here and ready to serve patients nationwide with HerResolve™, our blood-based test designed to aid healthcare providers in diagnosing endometriosis.

Attending ASRM? Come visit us at Booth #1127, directly across from ASRM Central on the exhibit floor!

Stop by to meet our team, see our new shipping box design, and learn more about how HerResolve™ can support endometriosis evaluation in clinical practice.

We look forward to seeing you in Baltimore!

🌐 https://heranova.com/products/



The Funk'tional Nutritionist has launched a dedicated podcast series on endometriosis and painful periods.Host Erin Holt...
10/23/2026

The Funk'tional Nutritionist has launched a dedicated podcast series on endometriosis and painful periods.

Host Erin Holt, a functional nutritionist, opens the series with Rachel Heintz, a registered dietitian and lead practitioner at The Funk'tional Nutritionist.

They explore painful periods, endometriosis symptoms beyond pelvic pain, and the challenges of getting a diagnosis. Rachel also explains how HerResolve™ analyzes blood biomarkers associated with endometriosis.

Thank you, Erin and Rachel, for discussing HerResolve™ with your audience and encouraging women to seek answers when their symptoms are dismissed!

Listen to the podcast episode, "Episode 426: Endo Uncovered Part 1: Painful Periods, Endometriosis & the Symptoms Women Are Told to Ignore": https://www.thefunktionalnutritionist.com/podcast/426-endo-series

A fresh packaging look for HerResolve™!The updated packaging features a refined HerAnova look for HerResolve™, our blood...
10/20/2026

A fresh packaging look for HerResolve™!

The updated packaging features a refined HerAnova look for HerResolve™, our blood-based test designed to aid healthcare providers in diagnosing endometriosis.

Considering testing? Our products page includes a list of U.S. clinics offering HerResolve™.

Interested in offering HerResolve™ in your practice or have questions about accessing testing? Connect with our team through our inquiry form here: https://heranova.com/products/

We'd love to hear from you!

How does IVFMD use HerResolve™ in patient care?Katherine L. Palmerola, MD, FACOG, a board-certified OB-GYN at IVFMD in M...
10/16/2026

How does IVFMD use HerResolve™ in patient care?

Katherine L. Palmerola, MD, FACOG, a board-certified OB-GYN at IVFMD in Miami, with fellowship training in Reproductive Endocrinology and Infertility, shares how she's using HerAnova's endometriosis blood test.

She explains HerResolve™, walks through three patient cases, and discusses how the results are informing next steps in evaluation.

Thank you, Dr. Palmerola, for sharing your experience and helping patients understand their testing options!

Watch the reel for her perspective on HerResolve™ in practice: https://www.instagram.com/reels/Ddm2j6hTWzB/

Heading to American Society for Reproductive Medicine? Let's talk endometriosis in fertility care! HerAnova will be in B...
10/14/2026

Heading to American Society for Reproductive Medicine? Let's talk endometriosis in fertility care! HerAnova will be in Baltimore for the ASRM 2026 Scientific Congress & Expo from October 24 to 28.

New this year: we can get your clinic set up to order HerResolve™ right at our booth! Visit us at Booth #1127 during exhibit hours, October 26-28, to meet our team and get started.

HerResolve™ is a non-invasive, LDT-validated, blood-based test that confirms endometriosis in women with unexplained infertility or other symptoms. It's available nationwide and already offered in 160+ clinics across the U.S. Ready to bring it to your patients?

We'll discuss clinical use cases involving unexplained infertility, individualized IVF planning, and treatment decisions, alongside real-world data from the first nine months since launch. Bring your questions and share your perspective!

Prefer to plan ahead or can't join us in Baltimore? We'd love to connect! Email [email protected] to schedule an individual meeting or a virtual meeting.

Congress details: https://asrmcongress.org/

HerAnova is a finalist for the Femtech Company of the Year Award!We're thrilled to be one of three companies shortlisted...
10/07/2026

HerAnova is a finalist for the Femtech Company of the Year Award!

We're thrilled to be one of three companies shortlisted in the Health Tech World Awards 2026.

Women with endometriosis can spend years seeking a diagnosis while pain and often infertility disrupt work, relationships, and everyday life. That's why our work in endometriosis and infertility matters so deeply to us and why we're proud to see it recognized.

This milestone gives us a moment to celebrate the research, persistence, and collaboration behind our progress. We're grateful to our team and the healthcare professionals working alongside us to advance women's health.

Thank you, Health Tech World, for recognizing HerResolve™, the first commercially available non-invasive blood-based endometriosis test in the U.S., and including HerAnova on this year's shortlist! Congratulations to our fellow finalists, Natural Cycles and SheMed.

Read the full shortlist announcement: https://htworld.co.uk/health-tech-world-awards/three-femtech-companies-shortlisted-for-health-tech-world-award-ftcat/

What does it take to build a women's health therapeutic pipeline?HerAnova's Chief Scientific Officer, Marcel van Duin, P...
10/05/2026

What does it take to build a women's health therapeutic pipeline?

HerAnova's Chief Scientific Officer, Marcel van Duin, PhD, brings more than 30 years of pharmaceutical R&D leadership in women's health and reproductive medicine.

His experience spans senior roles at Organon, Ferring, Merck, and Schering-Plough. Dr. van Duin has contributed to R&D strategies and product pipelines, and his work includes nearly 100 manuscripts, abstracts, and patents.

At HerAnova, Dr. van Duin's experience helps guide our work to advance integrated solutions for endometriosis and infertility.

Meet the rest of our team: https://heranova.com/about-us/

Address

2 Burlington Woods Drive Suite 100
Burlington, MA
01803

Alerts

Be the first to know and let us send you an email when HerAnova Lifesciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to HerAnova Lifesciences:

Shortcuts

Share

Nearby clinics